A knowledge resource selected by UNICEF for humanitarian practitioners everywhere

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing

This interim guidance has been developed based on the advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) at its 5 January 2021 extraordinary meeting.

This document details recommended schedule to administer Pfizer–BioNTech COVID-19 vaccine doses, it details interchangeability with other vaccines, precautions, considerations for deferring the second dose, indications for the vaccination of specific population (e.g. older people) etc.

Source

WHO

Area of Work

COVAX

Type

Technical Notes or Guidelines

Language

English

Year Published

2021

Last Checked

03/02/2021

DD/MM/YYYY

Region

Global